» Articles » PMID: 18287193

Improving Evaluation of Primary Gastric Malignancies by Distending the Stomach with Milk Immediately Before 18F-FDG PET Scanning

Overview
Specialty Nuclear Medicine
Date 2008 Feb 22
PMID 18287193
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: This study was designed to investigate the feasibility and effectiveness of a modified protocol for (18)F-FDG PET that was proposed to improve the identification of primary gastric malignancies.

Methods: In the modified protocol, patients were asked to drink 300-500 mL of cow milk to distend the stomach immediately before PET scans instead of fasting all along. For investigation of the influence of ingested milk on (18)F-FDG distributions, 43 nondiabetic patients without documented gastric diseases underwent both empty- and distended-stomach PET scans (79 and 72 scans, respectively) in their serial follow-up studies. For the evaluation of proven gastric malignancies, 24 patients who underwent distended-stomach PET scans were compared with 17 patients who underwent conventional empty-stomach examinations.

Results: Ingestion of milk nearly 1 h after (18)F-FDG injection had no significant influence on distributions to the heart (P = 0.16), mediastinum (P = 0.50), and liver (P = 0.49), whereas the percentages of intense and moderate uptake in the stomach changed from 38.0% and 59.5% to 0% and 11.1%, respectively. With the normal gastric wall distended, malignant lesions were observed with higher contrast and clearer outlines, and some of them were detected at a small size (1.2 cm) at an early stage and with mild uptake.

Conclusion: Gastric distention with milk just before (18)F-FDG PET is a simple and effective method for improving the evaluation of primary gastric malignancies.

Citing Articles

Quantitative Trait Locus Analysis and Identification of Candidate Genes Affecting Seed Size and Shape in an Interspecific Backcross Inbred Line Population of × .

Wu L, Jia B, Pei W, Wang L, Ma J, Wu M Front Plant Sci. 2022; 13:837984.

PMID: 35392518 PMC: 8981304. DOI: 10.3389/fpls.2022.837984.


Glucose metabolism in gastric cancer: The cutting-edge.

Yuan L, Yamashita H, Seto Y World J Gastroenterol. 2016; 22(6):2046-59.

PMID: 26877609 PMC: 4726677. DOI: 10.3748/wjg.v22.i6.2046.


Incremental diagnostic utility of gastric distension FDG PET/CT.

Le Roux P, Duong C, Cabalag C, Parameswaran B, Callahan J, Hicks R Eur J Nucl Med Mol Imaging. 2015; 43(4):644-53.

PMID: 26487512 DOI: 10.1007/s00259-015-3211-6.


Diagnosis and evaluation of gastric cancer by positron emission tomography.

Wu C, Zhu Z World J Gastroenterol. 2014; 20(16):4574-85.

PMID: 24782610 PMC: 4000494. DOI: 10.3748/wjg.v20.i16.4574.


Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of ¹⁸F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature.

Shimada H, Okazumi S, Koyama M, Murakami K Gastric Cancer. 2011; 14(1):13-21.

PMID: 21331531 DOI: 10.1007/s10120-011-0017-5.